ARCHIVES

In Brief: BCDDP “Dramatically” Changed U.S. Medical Practice, Fink Says; *% Not too uch-DeVita

This article is from The Cancer Letter archive.

Vol. 04 No. 50 | December 15, 1978

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974